Where do we stand in developing radionuclides against molecular markers overexpressed on breast cancer (BC) cells such as EGFR-family members?
Willy Vangu
nuclear medicine, Johannesburg, South Africa
nuclear medicine, Johannesburg, South Africa
New User? Click here to register
Text generated by AI based on an exclusive interview, revised and reviewed by
9.15 I 9.30
Corinne BALLEYGUIER
Dalila AHNOU
Copyright © 2025 - BCU